CClinicalTrials.gg
Active, not recruitingNCT07346872Updated Jan 16, 2026

EXORA Block vs Epidural Analgesia in Gynecological Surgery

An interventional study of Tramadol and exora block in Pain and Postoperative Pain, sponsored by Bursa Yuksek Ihtisas Training and Research Hospital. Active, not recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-16.

Sponsored by Bursa Yuksek Ihtisas Training and Research Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This prospective observational study aims to compare the effects of the EXORA block and epidural analgesia on postoperative pain control and quality of recovery in patients undergoing gynecological surgery. Quality of recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire, and postoperative pain will be evaluated using the Visual Analog Scale (VAS).

Read the detailed description

Effective postoperative analgesia is essential for improving recovery quality and patient satisfaction following gynecological surgery. Epidural analgesia is widely accepted as a standard technique for postoperative pain control; however, it may be associated with adverse effects such as hypotension and delayed mobilization. The EXORA block is an ultrasound-guided fascial plane block that has recently emerged as an alternative analgesic technique with a potentially favorable safety and recovery profile.

This prospective observational study compares postoperative recovery quality and analgesic efficacy between patients receiving EXORA block and those receiving epidural analgesia for postoperative pain management. Recovery quality will be objectively evaluated using the validated Quality of Recovery-15 (QoR-15) questionnaire.

02

Conditions studied

  • Pain
  • Postoperative Pain
03

In context

Pain

2,216 studies on the registry are indexed under Pain; 915 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 1,901 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Bursa Yuksek Ihtisas Training and Research Hospital is the lead sponsor of 45 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 18 to 80 years
  • ASA (American Society of Anaesthetists) physical status classification I-III
  • Undergoing elective gynecological surgery
  • Receiving either EXORA block or epidural analgesia for postoperative pain management

Exclusion criteria

Exclusion Criteria:

  • Secondary or repeat surgical procedures
  • Severe renal or hepatic dysfunction
  • Body mass index (BMI) greater than 30 kg/m²
  • Psychiatric or cognitive disorders impairing cooperation or questionnaire completion
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Group : exora block

    Patients will receive an ultrasound-guided EXORA block for postoperative analgesia, performed by the attending anesthesiologist according to institutional clinical practice.

    Drug: Tramadol · Procedure: exora block

  • Active comparator
    Group:Epidural Analgesia

    Patients will receive epidural analgesia for postoperative pain control, administered by the attending anesthesiologist according to standard institutional protocols.

    Drug: Tramadol · Procedure: epidural

Interventions

  • DrugTramadol

    400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; Patient-controlled analgesia settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

  • Procedureexora block

    Ultrasound guided External Oblique And Rectus Abdominis Plane (EXORA) Block block (0.3 ml/kg , %0.25 bupivacaine) will be performed

  • Procedureepidural

    Thoracic epidural catheterization will be performed preoperatively at the Thoracic 8-Thoracic 10 levels. Postoperatively, a bolus dose of 10 ml of 0.25% local anesthetic will be administered followed by continuous infusion.

06

What researchers measure

Primary outcomes

  1. NRS

    The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    Time frame: Postoperative 24 hours

Secondary outcomes

  1. Quality of Recovery-15 (QoR-15) Score

    The QoR-15 is a reliable and validated tool for assessing patient-reported postoperative recovery and provides a comprehensive evaluation of physical and emotional well-being after surgery.

    Time frame: Postoperative 24 hours

  2. Total Postoperative Tramadol Consumption (mg)

    Total amount of tramadol administered for postoperative analgesia will be recorded in milligrams during the first 24 hours after surgery.

    Time frame: Postoperative 24 hours]

  3. Incidence and Severity of Postoperative Nausea and Vomiting Assessed by the Nausea and Vomiting Scale (NVS)

    Postoperative nausea and vomiting will be assessed using the Nausea and Vomiting Scale (NVS), defined as: 0 = No nausea 1. = Mild nausea 2. = Severe nausea 3. = Vomiting In cases of an NVS score ≥3, an antiemetic drug will be administered.

    Time frame: Postoperative 24 hours

  4. Number of Participants Requiring Additional Postoperative Rescue Analgesia

    The number of participants requiring additional postoperative rescue analgesia beyond the standard analgesic protocol within the first 24 hours after surgery will be recorded.

    Time frame: postoperative 24 hour

  5. pinprick test

    The level of sensory block will be evaluated by pinprick test at 30 minutes following the block procedure and in postoperative patients. With the pinprick, the gently touches the skin with the pin or back end and asks the patient whether it feels sharp or blunt.

    Time frame: postoperative 24 hour

07

Study locations

2 sites
  • Korgün Ökmen
    Bursa, 16110, Turkey (Türkiye)
  • University of Health Sciences,,Bursa Yuksek Ihtisas Training and Research Hospital,
    Bursa, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07346872
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Responsible party
Korgün Ökmen (Principal Investigator, Bursa Yuksek Ihtisas Training and Research Hospital) — Principal investigator
First posted
Jan 16, 2026
Start date
Dec 26, 2025
Primary completion
Aug 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Jan 16, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion